RESUMEN
X-linked hypophosphataemia (XLH) rickets is a rare disease frequently misdiagnosed and mismanaged. Despite having clinical guidelines that offers some therapeutic recommendations based on the clinical experience of experts, physicians still have questions about some important aspects of the diagnosis and treatment of XLH, such as when the disease should be suspected, who should be in charge of the diagnosis, what should be done once the disease is diagnosed, or what therapeutic options are currently available. The objective of this paper is to answer some of the more frequent questions related to the management of patients with XLH by a group of experts participating in a scientific conference on XLH held in Madrid.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Quimioterapia/normas , Raquitismo Hipofosfatémico Familiar/diagnóstico , Raquitismo Hipofosfatémico Familiar/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Adolescente , Niño , Preescolar , Cálculo de Dosificación de Drogas , Femenino , Factor-23 de Crecimiento de Fibroblastos , Humanos , MasculinoRESUMEN
In the original article, there is an error in age related reference.